Skip to content

Physical Activity, Psychopathology, and Quality of Life in People With Psychotic or Affective Disorders

The Relationships Between Physical Activity, Psychopathological Symptoms, and Health-Related Quality of Life in People Diagnosed With Psychotic or Affective Disorders

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05869409
Enrollment
60
Registered
2023-05-22
Start date
2022-05-01
Completion date
2025-12-01
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Affective Disorder, Psychotic Disorders

Keywords

Physical Activity, Quality of Life

Brief summary

This longitudinal observational study tests the associations between physical activity, health-related quality of life, and psychopathology symptoms among people diagnosed with schizophrenia or diagnosed with affective disorders. It was assumed that higher levels of physical activity at baseline will be related to better quality of life (across physical, social, and psychological domains), and lower psychopathology symptoms (positive and negative symptoms of psychosis, general psychopathology, and depression severity) at 6-week follow-up measurement. Adult participants with a diagnosis of a psychotic disorder or a diagnosis of an affective disorder will be enrolled.

Interventions

BEHAVIORALPhysical activity and sedentary behavior education

Enrolled patients will participate in an individual face-to-face education session, addressing: definitions and examples of sedentary and physical activity behaviors; physical health-related and mental health-related consequences of these behaviors; ways to break sedentary behaviors; age-adjusted physical activity recommendations (based on the guidelines of the World Health Organization).

Sponsors

University of Social Sciences and Humanities, Warsaw
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\- a diagnosis of a psychotic disorder or affective disorder

Exclusion criteria

* major cognitive deficits, indicated by total scores \> 8 points, obtained with the Montreal Cognitive Assessment (MoCA) Scale at baseline

Design outcomes

Primary

MeasureTime frameDescription
Health-Related Quality of Lifechange from the baseline health-related quality of life at 6 weeksscores (range 0-100) obtained in the World Health Organization Quality of Life Questionnaire (WHOQOL-BREF); higher scores indicate better quality of life

Secondary

MeasureTime frameDescription
Positive Symptoms (Psychosis)change from the baseline positive symptoms at 6 weeksscores obtained with Positive and Negative Syndrome Scales (PANSS): Positive Symptoms subscale, scores range: 7-49; higher scores indicate more symptoms
Negative Symptoms (Psychosis)change from the baseline negative symptoms at 6 weeksscores obtained with Positive and Negative Syndrome Scales (PANSS): Negative Symptoms subcale, scores range: 7-49, higher scores indicate more symptoms
General Psychopathology Symptoms )Psychosis)change from the baseline general psychopathology symptoms at 6 weeksscores obtained with Positive and Negative Syndrome Scales (PANSS): General Psychopathology subscale, scores range: 16-112, higher symptoms indicate more symptoms
Depression symptomschange from baseline depression symptoms at 6 weeksscores obtained in Patient Health Questionnaire -9 (PHQ-9); scores range: 0-36; higher scores indicate more severe symptoms of depression
Physical activitychange from baseline physical activity at 6 weeksminutes of physical activity per week measured with International Physical Activity Questionnaire - Short Form (IPAQ-Short Form); more minutes indicate more time spent on light, moderate, or high-intensity physical activity

Countries

Poland

Contacts

Primary ContactAleksandra Luszczynska, PhD
aluszczynska@swps.edu.pl0048604576066
Backup ContactErnest Swora, MA
eswora@swps.edu.pl

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026